Dashboard
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -0.41% and Operating profit at 1.97% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -14.95
The company declared negative results in Mar'25 after flat results in Dec'24
Risky - Negative EBITDA
Falling Participation by Institutional Investors
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Tour, Travel Related Services
USD 6 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
1.07
363.50%
-1.21
Total Returns (Price + Dividend) 
XWELL, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
Is XWELL, Inc. technically bullish or bearish?
As of 12 September 2025, the technical trend for XWELL, Inc. has changed from mildly bearish to bearish. The current technical stance is bearish with weak strength indicated by the mixed signals across different time frames. The MACD shows mildly bullish readings on both weekly and monthly charts, while the Bollinger Bands indicate a bearish monthly trend. The daily moving averages are mildly bullish, but the KST shows a bullish weekly signal contrasted by a bearish monthly signal. The OBV is mildly bearish on a monthly basis, and Dow Theory indicates no trend in both weekly and monthly time frames. In terms of performance, XWELL has significantly underperformed against the S&P 500 across multiple periods, with a year-to-date return of -27.54% compared to the S&P 500's 12.22%, and a one-year return of -41.80% versus 17.14%....
Read MoreIs XWELL, Inc. overvalued or undervalued?
As of 15 August 2022, the valuation grade for XWELL, Inc. moved from fair to risky, indicating a significant deterioration in its valuation outlook. The company appears to be overvalued given its negative price-to-book value of -0.86 and an EV to EBITDA ratio of 0.28, which suggests that the market is not pricing in the company's financial health appropriately. Additionally, the return on capital employed (ROCE) is exceptionally high at 96.86%, but this is overshadowed by the overall negative financial metrics. In comparison to its peers, XWELL, Inc. has a P/E ratio of -0.3332, while Afya Ltd. is considered attractive with a P/E of 11.8061, and Despegar.com Corp. is deemed expensive at 51.8610. The stark contrast in valuation ratios highlights XWELL's challenging position within the industry. Furthermore, the company's stock has significantly underperformed against the S&P 500, with a year-to-date return o...
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 3 Schemes (2.91%)
Held by 3 Foreign Institutions (0.05%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
QoQ Growth in quarter ended Jun 2025 is 10.00% vs -6.67% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is 54.35% vs 39.47% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 12.62% vs -46.15% in Dec 2023
YoY Growth in year ended Dec 2024 is 41.07% vs 14.11% in Dec 2023






